Guardant Health
GH
#1172
Rank
A$28.77 B
Marketcap
A$212.67
Share price
-0.52%
Change (1 day)
43.12%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): A-$5.14

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$5.18. In 2025 the company made an earnings per share (EPS) of A-$4.91 an increase over its 2024 EPS that were of A-$5.28.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.144.67%
2025A-$4.91-7.02%
2024A-$5.28-16.82%
2023A-$6.35-33.13%
2022A-$9.5060%
2021A-$5.9455.04%
2020A-$3.83207.14%
2019A-$1.25-19.81%
2018A-$1.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$0.38-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.64-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA